3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Lymphoma, Non-Hodgkin
5
Lymphoma
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Multiple Myeloma
2
Lymphoma, B-Cell
2
Leukemia
2
Hematologic Neoplasms
2
Burkitt Lymphoma
2
Philadelphia Chromosome
1
Myelodysplastic Syndromes
1
Metabolic Syndrome
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Primary Effusion
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, AIDS-Related
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, B-Cell
1
Hodgkin Disease
1
Heart Failure
1
Cardiovascular Diseases
1
Cardiotoxicity
1
Cardiomyopathies
1
Interventions
Rituximab
2
Lenalidomide
2
pegfilgrastim
1
obinutuzumab
1
acalabrutinib
1
Vincristine
1
Vascular Stiffness
1
Secondary Prevention
1
Pulse Wave Analysis
1
Prednisolone
1
Exercise
1
Eplerenone
1
Electrocardiography
1
Echocardiography
1
Doxorubicin
1
Dexrazoxane
1
Cyclophosphamide
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Heart Failure
×
Electrocardiography
×
Lymphoid
×
Clear all
NCT07041827
2025-06-27
CLARITY
The Netherlands Cancer Institute
Completed
217 enrolled